Just three months after winning backing from football star Kylian Mbappé, European health-insurance technology startup Alan has raised €400 million ($460 million) in fresh funding, lifting its valuation to €5.5 billion ($6.3 billion) as investors continue to bet on companies using artificial intelligence to reshape healthcare.

The funding round led by Prosus includes both primary and secondary equity. Existing investors Teachers’ Venture Growth (TVG) and Index Ventures also participated, alongside new investor Dara Holdings. The investment comes as demand grows for AI-powered healthcare services that combine insurance, medical care, and preventive health support in a single platform.

The financing marks another milestone for Alan, which has spent the past decade expanding beyond traditional health insurance. Rather than reimbursing medical bills, Alan is positioning itself as a platform that encourages users to manage their health before illnesses become more serious, an approach it believes can reduce costs while improving patient outcomes.

That strategy has also translated into stronger financial performance. Alan reported annual recurring revenue of more than €800 million ($920 million) in the first quarter of 2026, up 53 percent from a year earlier. The company is profitable in France, its largest market, serves more than 1.1 million members and has continued to grow without a comparable increase in staffing, reflecting the efficiencies created by its AI-driven technology.

Prosus backs Alan’s AI expansion

Prosus said the investment will strengthen both companies. The technology investor expects to support Alan’s expansion into larger international markets where Prosus already has an established presence, while also accelerating the startup’s AI product development through access to Prosus’ Large Commerce Model. In return, Alan will broaden Prosus’ consumer ecosystem by adding healthcare services to its long-term strategy.

“Health can’t wait, not for symptoms to get worse, not for a six-month appointment, not for the system to catch up,” Jean-Charles Samuelian-Werve, Alan’s co-founder and chief executive officer, said in a statement. “We believe great health is a universal right, and that prevention should be too.”

Samuelian-Werve said Alan chose Prosus because of its experience helping technology businesses expand internationally and its expertise in building consumer-focused products. “We are still at the very beginning of what Alan can become,” he added.

Prosus also sees healthcare as one of artificial intelligence’s biggest commercial opportunities. “Healthcare presents one of the most significant global opportunities for AI-led transformation,” Fahd Beg, Head of Investments at Prosus Group, said in a statement. He said Alan has created an integrated platform where insurance, prevention and care work together, giving consumers a better healthcare experience while creating a stronger business.

Mbappé-backed Alan enters new phase

Alan now operates in France, Spain, Belgium and Canada, serving more than 37,000 businesses as well as self-employed workers and retirees. The company employs more than 850 people and says its focus on digital services has helped it maintain consistently high customer satisfaction as it expands across Europe and North America.

The latest investment also builds on growing confidence from high-profile backers. In March, Real Madrid forward Kylian Mbappé invested in Alan through his investment firm, Coalition Capital, as the French unicorn marked its 10th anniversary. His participation formed part of a €100 million funding round completed earlier this year.

Although the size of Mbappé’s holding has not been disclosed, Samuelian-Werve previously described the footballer’s investment as significant. Beyond providing capital, the partnership is designed to raise Alan’s profile in France and abroad while helping develop new services within the company’s app for its more than 1.1 million users.

“Just like in sports, I want to build for the long term by investing in projects that align with my values,” Mbappé said when the partnership was announced. “When it comes to prevention and health, it’s essential in my profession.”

With fresh capital, a profitable home market and support from both global investors and one of football’s biggest names, Alan is entering its next phase with stronger financial backing as competition intensifies in the race to modernize healthcare through artificial intelligence.